CSL - Current Assets

Stock Price
140.66
Daily Change
-0.37 -0.26%
Monthly
-7.19%
Yearly
-43.25%
Q1 Forecast
138.07

CSL reported $11.85B in Current Assets for its fiscal semester ending in December of 2025.





Current Assets Change Date
Alterity Therapeutics Limited AUD 27.05M 6.16M Jun/2023
Arca Biopharma USD 355.16M 23.15M Sep/2025
aTyr Pharma USD 93.01M 5.52M Sep/2025
Bio Path USD 680K 1.44M Jun/2025
Brainstorm Cell Therapeutics USD 508K 1.01M Sep/2025
Cara Therapeutics USD 43.13M 4.18M Jun/2025
CSL USD 11.85B 1000K Dec/2025
Curis USD 14.42M 10.39M Jun/2025
Esperion Therapeutics USD 462.57M 102.11M Dec/2025
Immunic USD 39.27M 20.57M Sep/2025
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Minerva Neurosciences USD 83.1M 70.08M Dec/2025
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
TherapeuticsMD USD 11.82M 303K Jun/2024